Investment for health and wellbeing
Q1 2025 published - read moreOriola operates in the Finnish and Swedish health and wellbeing markets
Oriola serves the health and wellbeing market with modern and customer-focused products and services, and connects all actors within the field, from pharmaceutical companies to pharmacies and consumers.
Interim Report Q1 2025
Steady growth and progress towards long-term goals - outlook refined
Annual Report 2024
Growth through strategy implementation. Find out more about Oriola's year 2024.
Annual General Meeting 2025
Key resolutions from the AGM held on 2 April: A dividend of EUR 0.07 per share shall be paid for the financial year 2024. The AGM approved a shareholder's proposal to combine the company's A and B share classes after which the company will have only one single share class.
